Correction to "Unique Positive Cooperativity Between the β-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor".
Publication
, Journal Article
Published in: Mol Pharmacol
December 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Mol Pharmacol
DOI
EISSN
1521-0111
Publication Date
December 2021
Volume
100
Issue
6
Start / End Page
597
Location
United States
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1109 Neurosciences
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Correction to "Unique Positive Cooperativity Between the β-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor". (2021). Mol Pharmacol, 100(6), 597. https://doi.org/10.1124/molpharm.121.000363err
“Correction to "Unique Positive Cooperativity Between the β-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor".” Mol Pharmacol 100, no. 6 (December 2021): 597. https://doi.org/10.1124/molpharm.121.000363err.
“Correction to "Unique Positive Cooperativity Between the β-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor".” Mol Pharmacol, vol. 100, no. 6, Dec. 2021, p. 597. Pubmed, doi:10.1124/molpharm.121.000363err.
Published In
Mol Pharmacol
DOI
EISSN
1521-0111
Publication Date
December 2021
Volume
100
Issue
6
Start / End Page
597
Location
United States
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1109 Neurosciences
- 0601 Biochemistry and Cell Biology